Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportPoster - PhysicianPharm

Influence of Aβ and neurofibrillary tau deposition on cognition in Down syndrome across the Alzheimer’s disease continuum

Matthew Zammit, Alexandra DiFilippo, Tyler Tullis, Andrew McVea, Dana Tudorascu, Charles Laymon, Ann Cohen, Shahid Zaman, Beau Ances, Sigan Hartley, Sterling Johnson, Charles Stone, Chester Mathis, William Klunk, Benjamin Handen and Bradley Christian
Journal of Nuclear Medicine May 2021, 62 (supplement 1) 1592;
Matthew Zammit
1University of Wisconsin-Madison Madison WI United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexandra DiFilippo
1University of Wisconsin-Madison Madison WI United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tyler Tullis
1University of Wisconsin-Madison Madison WI United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew McVea
1University of Wisconsin-Madison Madison WI United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dana Tudorascu
2University of Pittsburgh Pittsburgh PA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charles Laymon
2University of Pittsburgh Pittsburgh PA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ann Cohen
2University of Pittsburgh Pittsburgh PA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shahid Zaman
3University of Cambridge Cambridge United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Beau Ances
4Washington University in St. Louis St. Louis MO United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sigan Hartley
1University of Wisconsin-Madison Madison WI United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sterling Johnson
1University of Wisconsin-Madison Madison WI United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charles Stone
1University of Wisconsin-Madison Madison WI United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chester Mathis
2University of Pittsburgh Pittsburgh PA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
William Klunk
2University of Pittsburgh Pittsburgh PA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Benjamin Handen
2University of Pittsburgh Pittsburgh PA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bradley Christian
1University of Wisconsin-Madison Madison WI United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

1592

Introduction: Adults with Down syndrome (DS) have a high incidence of Alzheimer’s disease (AD). In late-onset AD, tau has been shown to have greater impact on cognition compared to Aβ, but the effects of tau on cognition have not yet been evaluated in DS. The aim of this study was to examine the association between Aβ and tau with cognition in a large DS cohort.

Methods: A total of 161 adults with DS (mean age: 39.2 [8.46] years) and 40 healthy, non-DS sibling controls (43.2 [12.6] years) underwent T1w-MRI, [C-11]PiB and [F-18]AV-1451 PET scans at four imaging sites. MRI images were processed using FreeSurfer v5.3.0 to generate ROI masks encompassing the Braak staging of tau pathology. PiB and AV-1451 SUVr images were generated using a cerebellar gray matter reference region. Global Aβ burden was calculated using the amyloid load metric (AβL). A low-threshold amyloid-positivity (A+) cutoff was defined as 13.3 AβL (~18 Centiloids). Regional tau was assessed using AV-1451 SUVr Z-scores. A Z-score cutoff for tau-positivity (T+) was defined as 3.90 from the sibling control data (97.5th percentile of maximum Z-score values). No corrections for the partial volume effect were performed, so analyses were restricted to Braak regions III-VI. Z-score composite measures of episodic memory and overall cognition (includes measures of episodic memory, dementia symptoms/mental status, visual perception, executive functioning, motor planning and coordination, and verbal fluency) were compared between adults with DS who were A+T- versus A+T+ across each Braak region using two-sample t-tests while adjusting for age, premorbid level of intellectual disability, and imaging site.

Results: Of the 20 A+T+ DS individuals, six were cognitively stable (CS-DS), five had mild cognitive impairment (MCI-DS), seven had AD, and two had a consensus of unable to be determined (Figure 1). The cognitive consensus was determined independent of imaging data. There were no participants classified as A-T+. T+ classification resulted in fewer CS-DS cases when compared to A+ classification. Compared to those that were only Braak III T+, Braak IV T+ revealed fewer CS-DS cases. Figure 2 displays the associations between cognition, Aβ, and regional tau. Participants with an A+T+ classification displayed significantly worse cognitive functioning compared to those with an A+T- classification (Table 1). Discussion: These findings reveal that T+ classification was better able to distinguish cases of MCI-DS and AD from CS-DS compared to A+ classification alone. The A+T+ individuals displayed worse cognitive functioning compared to the A+T- individuals, suggesting T+ presence in DS is a better indicator of cognitive decline, similar to the observations in late-onset AD.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 62, Issue supplement 1
May 1, 2021
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Influence of Aβ and neurofibrillary tau deposition on cognition in Down syndrome across the Alzheimer’s disease continuum
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Influence of Aβ and neurofibrillary tau deposition on cognition in Down syndrome across the Alzheimer’s disease continuum
Matthew Zammit, Alexandra DiFilippo, Tyler Tullis, Andrew McVea, Dana Tudorascu, Charles Laymon, Ann Cohen, Shahid Zaman, Beau Ances, Sigan Hartley, Sterling Johnson, Charles Stone, Chester Mathis, William Klunk, Benjamin Handen, Bradley Christian
Journal of Nuclear Medicine May 2021, 62 (supplement 1) 1592;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Influence of Aβ and neurofibrillary tau deposition on cognition in Down syndrome across the Alzheimer’s disease continuum
Matthew Zammit, Alexandra DiFilippo, Tyler Tullis, Andrew McVea, Dana Tudorascu, Charles Laymon, Ann Cohen, Shahid Zaman, Beau Ances, Sigan Hartley, Sterling Johnson, Charles Stone, Chester Mathis, William Klunk, Benjamin Handen, Bradley Christian
Journal of Nuclear Medicine May 2021, 62 (supplement 1) 1592;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Poster - PhysicianPharm

  • Preliminary result of Texture Analysis on prediction of overall outcome of neuroendocrine tumors based on pre-therapy heterogeneity of somatostatin receptors on 68Ga Dotatate PET/CT scans.
  • Low brain FDG uptake in lymphoma patients represents preferential use of high blood lactate released by total lesion glycolysis.
  • The triglyceride HDL cholesterol ratio: an independent predictor of obstructive coronary artery disease and myocardial ischemia in patients with chronic coronary syndrome
Show more Poster - PhysicianPharm

Basic Neurosciences

  • 18F-FAC PET images brain-infiltrating leukocytes and peripheral immune activation in an experimental autoimmune encephalomyelitis model of multiple sclerosis
  • Monoamine Oxidase-A is Upregulated in Post-Mortem Human Alzheimer’s Disease and Parkinson’s Disease Brain
Show more Basic Neurosciences

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire